Northeastern University

Page Content   Main Links   Local Links   Utility Links   Footer Links

Bouvé College of Health Sciences at Northeastern University


Drug discovery symposium maps new frontiers, collaborations

Print this Page   Home > News > 2012 > Drug discovery symposium maps new frontiers, collaborations

November 09, 2012


More than 300 stu­dents, fac­ulty and industry researchers from more than 80 insti­tu­tions con­vened at North­eastern Uni­ver­sity on Tuesday for a day­long sym­po­sium on the future of drug dis­covery and devel­op­ment with an eye toward treating debil­i­tating diseases.

The event took place in the Curry Stu­dent Center and was co-​​hosted by Terry Fulmer, dean of the Bouvé Col­lege of Health Sci­ences and Murray Gibson, dean of the Col­lege of Sci­ence. "Our dis­tin­guished speakers really gave us a lens into the future which is so exciting," said Fulmer. Gibson praised the symposium's col­lab­o­ra­tive nature, saying, "We were delighted to have out­standing external leaders describe the cut­ting edge of drug dis­covery, in the con­text of our leading efforts here at North­eastern, and inform our future plans."

Graham Jones, chair of Northeastern's depart­ment of chem­istry and chem­istry biology, explained that a common theme that emerged throughout the day was the need for "col­lab­o­ra­tion and inte­gra­tion to pre­vent dupli­ca­tion of effort among devel­opers, and to ensure com­pa­nies invest cap­ital in the most promising areas."

In one of three keynote speeches, pio­neering chemist George White­sides noted the remark­able fact that he was "here, in front of you, alive." Despite being exposed to thou­sands of harmful pathogens on a reg­ular basis, he said, our life expectancy out­paces that of our ances­tors by decades. "We are selected to be phe­nom­e­nally robust as com­plex sys­tems," said White­sides, a Har­vard Uni­ver­sity pro­fessor whose work has fun­da­men­tally changed the par­a­digm of sci­ence in var­ious ways.

World-​​renowned sys­tems biol­o­gist Leroy Hood, whose ground-​​breaking work paved the way for the Human Genome Project, agreed: "It's clear that one of the enor­mous chal­lenges in studying dis­ease is the incred­ible com­plexity of living organ­isms," said Hood, who served as the fea­tured speaker on Monday at Northeastern's Pro­files in Inno­va­tion Pres­i­den­tial Speaker Series.

The pro­gram of 11 speakers, which included researchers from industry as well as acad­emia, tackled these and other chal­lenges facing the field with a morning ses­sion chaired by Man­soor Amiji, chair of the depart­ment of phar­ma­ceu­tical sci­ences, and an after­noon ses­sion chaired by Jones. Isabel Cunha-​​Vasconcelo, the director of cor­po­rate & foun­da­tion rela­tions and research advance­ment in the Bouve Col­lege of Health Sci­ences, helped orga­nize the event, which cov­ered a variety of topics including an overview on the state of cystic fibrosis therapy research and a dis­cus­sion of new antiviral com­pounds through the story of Darunavir, a front­line AIDS/​HIV drug.

The third keynote address, given by Carnegie Mellon bio­med­ical engi­neering pro­fessor Alan J. Rus­sell, focused on the cur­rent state of regen­er­a­tive med­i­cine. "The holy grail is really drug induced regen­er­a­tion," he said, indi­cating that the field will ulti­mately move away from more inva­sive processes that involve whole cell injections.

The event, which also fea­tured an expo­si­tion of Northeastern's myriad con­tri­bu­tions in the field, "was a striking suc­cess," said Fulmer. "New inves­ti­gator to inves­ti­gator con­tacts were estab­lished and poten­tial new col­lab­o­ra­tions mapped out."

Main Links

Local Links

Text Only Options

Top of page

Text Only Options

Open the original version of this page.

Usablenet Assistive is a UsableNet product. Usablenet Assistive Main Page.